‘Teva’ Launches Generic Drug Against Depression
Teva Pharmaceutical Industries launched its generic version of Forest Laboratories’ Lexapro, for the treatment of depression and generalized anxiety disorder. Teva will enjoy six months of marketing exclusivity, as it was the first company to file an Abbreviated New Drug Application with the FDA. Lexapro has been a major revenue generator for Forest Labs with the […]
March 15, 2012
Report: ‘NDS’ To Be Sold For $5 Billion
Computer communications giant Cisco Systems is in advanced talks to acquire NDS for $5 billion, Israeli website Calcalist reported. NDS, founded in 1988, is a provider of software solutions for the pay television industry. The company is currently owned by Permira Advisors and News Corp, controlled by Rupert Murdoch. Its headquarters are based in the […]
March 15, 2012
Microsoft Launches First Startup Accelerator In Israel
Microsoft has launched the first startup accelerator in the company’s history, to encourage early-stage startups to build cloud-based applications using Windows Azure. As part of the program, Microsoft will provide the participants workspace and coaching. The four-month program will take place at the Microsoft Israel Research and Development Center in Herzliya Pituach, Israel. View and share
March 14, 2012
‘Radvision’ To Be Acquired For More Than $200M
Avaya plc is set to acquire video conferencing solutions developer Radvision, Israeli media reports. Avaya, a provider of business collaboration and communications solutions to companies around the world, will buy the Israeli company for $200-250 million. The deal is expected to be sealed by the end of this week. Radvision was founded in 1992 and […]
March 14, 2012
IBM Launches Cancer Analytics Platform
IBM launched an analytics platform that offers personalized treatments for a wide range of long-term health issues including cancer, hypertension and AIDS. The biomedical platform, named Clinical Genomics, was developed by IBM researchers in Haifa, Israel and combines personal health history with an analysis of guidelines and similar cases. The platform will deliver treatment recommendations […]
March 14, 2012
Investment Network ‘eToro’ Secures $15M
Investment network eToro announced that it has closed a funding round of $15 million from Spark Capital and other investors to fuel international growth and further development of its social trading platform. The new round takes the total amount of funding in the Israel-based company to $33.9 million. eToro’s community powered network enables every investor to […]
March 13, 2012
‘superDimension’ To Be Sold To Covidien Plc For $350M
Medical device company superDimension is in the process of being acquired by Covidien Plc, for $350 million, Israeli website Calcalist reported. The deal is anticipated to be sealed by the end of this week. superDimension develops pulmonary devices that are mostly used to diagnose lung cancer. It was founded in 1995 in Israel and is headquartered […]
March 13, 2012
‘Mazor Robotics’ Signs Distribution Agreement In China
Mazor Robotics, Israeli developer of surgical robots and complementary products for spine surgery, signed an agreement with Cicel Science & Technology to distribute its Renaissance system in China. As part of the agreement, Cicel is committed to purchase three Renaissance systems for surgical guidance and will use these systems to pursue regulatory clearance from the State Food […]
March 12, 2012
SXSW: Israeli ‘Fooducate’ Wins App Competition
Israeli startup Fooducate has won the mobile application competition “Command the Spotlight” at the SXSW conference in Austin, Texas. The competition was organized by analytics company Flurry. According to the blog VentureBeat, Fooducate was one of three selected apps that beat their 700 competitors. Fooducate provides nutritional information about grocery store items after analyzing information found in each product’s nutrition panel […]
March 12, 2012
NeuroPhage Raises $9M For Neurodegenerative Diseases Treatment
NeuroPhage Pharmaceuticals, a privately held biotechnology company focused on the treatment and prevention of neurodegenerative diseases, announced that it has secured $9 million. The funding round that was completed by existing investors and private investors brings the total amount of equity capital raised by NeuroPhage since its inception in 2006 to $28.6 million. NeuroPhage, which […]
March 12, 2012
File Security Platform ‘WatchDox’ Raises $9M
WatchDox, the developer of file sharing security solutions, has raised $9 million. The funding was led by investment and advisory firm Blackstone and included the company’s current investors – Chairman Shlomo Kramer, Shasta Ventures and Gemini Israel Funds. The company, based in Petah Tikva, Israel, and Sillicon Valley, provides solutions to access, share and control […]
March 11, 2012
‘Kamada’ Obtains FDA Approval For Cystic Fibrosis Drug Trial
Israeli bio-pharmaceutical company Kamada announced that it has obtained FDA approval to conduct a clinical trial in the US for the company’s next generation drug for the treatment of cystic fibrosis. The drug is an inhalable version of company’s AAT drug (Alpha-1 Antitrypsin deficiency). The current FDA approval is partly based on successful pre-clinical trials of the […]
March 11, 2012
‘Teva’ Gets FDA Approval For Inhaler With Dose Counter
Teva Respiratory, the U.S.-based respiratory subsidiary of Israeli Teva Pharmaceutical Industries announced that the FDA has approved its quick relief inhaler ProAir HFA with a dose counter, for the treatment or prevention of breathing disorders in patients four years of age and older. The dose counter is designed to help patients suffering drom disorders such […]
March 08, 2012
‘Vascular Dynamics’ Raises $13.2m For High Blood Pressure Treatment
Vascular Dynamics has raised $13.2 million at a company value of $31 million in a funding round led by an equity fund, whose name was not disclosed. Vascular dynamics developed a passive, catheter-delivered stent implant for the treatment of high blood pressure. The stent is in its preclinical stage. The company was founded in 2008 at Rainbow […]
March 08, 2012
‘Virdia’ Secures $105 Million In Public And Private Financing
Virdia, a leading developer of cellulosic sugars, announced its latest funding round of $30 million in private financing and a $75 million deal with the Mississippi Development Authority to build manufacturing plants in the State. Founded in 2007 as HCL CleanTech, Virdia has developed the CASE process, which converts wood into sugars that can be […]
March 07, 2012